文献速递脑血管病外科神经重症

红细胞输血对动脉瘤性蛛网膜下腔出血后功能结局的影响

The Effects of Red Blood Cell Transfusion on Functional Outcome after Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2017-10-14

本研究基于前瞻性观察数据库回顾性纳入421例接受手术夹闭的动脉瘤性蛛网膜下腔出血患者,采用倾向评分方法分析红细胞输血与迟发性脑缺血、血管痉挛及6个月功能结局的关联。结果显示输血与不良结局相关,尤其在无迟发性脑缺血时;存在迟发性脑缺血时输血可能改善结局。

要点

  • 421例患者中62.0%接受红细胞输血,67.2%获得良好功能结局。
  • 输血与血管造影性血管痉挛相关(OR 1.6;95%CI 1.1-2.3;P=0.025)。
  • 无迟发性脑缺血时输血与不良结局相关(OR 2.17;95%CI 1.56-3.01;P<0.0001)。

核心结论

  • 输血与动脉瘤性蛛网膜下腔出血后不良结局相关,尤其在无迟发性脑缺血时;存在迟发性脑缺血时输血可能有助于改善结局。

研究设计与样本

  • 回顾性识别自前瞻性观察数据库的421例连续动脉瘤性蛛网膜下腔出血患者,均于大学附属医院神经重症监护室接受手术闭塞破裂动脉瘤,采用倾向评分方法减少治疗选择偏倚。

主要发现

  • 261例(62.0%)接受红细胞输血;血管造影性血管痉挛与输血相关(OR 1.6;95%CI 1.1-2.3;P=0.025),而严重血管造影痉挛、迟发性脑缺血或迟发性梗死与输血无关。
  • 283例(67.2%)获得良好结局(格拉斯哥结局量表良好或中度残疾),47例(11.2%)为严重残疾或植物状态,91例(21.6%)在6个月随访时死亡。
  • 在存活≥2天的患者中,输血与不良结局相关(OR 2.6;95%CI 1.6-4.1)。
  • 输血≥3单位与不良结局发生率增加相关。
  • 倾向分析显示,无迟发性脑缺血时输血与不良结局相关(OR 2.17;95%CI 1.56-3.01;P<0.0001),存在迟发性脑缺血时无此关联(OR 0.82;95%CI 0.35-1.92;P=0.65)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal red blood cell transfusion (RBCT) trigger for patients with aneurysmal subarachnoid hemorrhage (SAH) is unknown. In patients with cerebral vasospasm, anemia may increase susceptibility to ischemic injury; conversely, RBCT may worsen outcome given known deleterious effects. OBJECTIVE: To examine the association between RBCT, delayed cerebral ischemia (DCI), vasospasm, and outcome after SAH. METHODS: A total of 421 consecutive patients with SAH, admitted to a neurocritical care unit at a university-affiliated hospital and who underwent surgical occlusion of their ruptured aneurysm were retrospectively identified from a prospective observational database. Propensity score methods were used to reduce the bias associated with treatment selection. RESULTS: Two hundred and sixty-one patients (62.0%) received an RBCT. Angiographic vasospasm (odds ratio [OR] 1.6; 95% confidence interval [CI], 1.1-2.3; P = 0.025) but not severe angiographic spasm, DCI, or delayed infarction was associated with RBCT. A total of 283 patients (67.2%) experienced a favorable outcome, defined as good or moderately disabled on the Glasgow Outcome Scale; 47 (11.2%) were severely disabled or vegetative and 91 patients (21.6%) were dead at 6-month follow-up. Among patients who survived ≥2 days, RBCT was associated with unfavorable outcome (OR, 2.6; 95% CI, 1.6-4.1). Transfusion of ≥3 units of blood was associated with an increased incidence of unfavorable outcome. Propensity analysis to control for the probability of exposure to RBCT conditional on observed covariates measured before RBCT indicates that RBCT is associated with unfavorable outcome in the absence of DCI (OR, 2.17; 95% CI, 1.56-3.01; P < 0.0001) but not when DCI is present (OR, 0.82; 95% CI, 0.35-1.92; P = 0.65). CONCLUSIONS: Blood transfusions are associated with unfavorable outcome after SAH particularly when DCI is absent. Propensity analysis suggests that RBCT may be associated with poor outcome rather than being a marker of disease severity. However, when DCI is present, RBCT may help improve outcome.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kumar MA, Levine J, Faerber J, et al. The Effects of Red Blood Cell Transfusion on Functional Outcome after Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2017. PMID: 29038077. doi:10.1016/j.wneu.2017.09.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。